Previous 10 | Next 10 |
24/7 Market News news releases related 24/7 Market News news releases and 24/7 Market News press releases from 09/14/23 09:07:26 on US and Canada Markets.
2023-09-14 09:07:26 ET (24/7 MARKET NEWS) – First Wave BioPharma, Inc. (NASDAQ:FWBI) stated, this morning, that it signed an agreement to license Sanofi’s (NASDAQ:SNY) selective 5-HT4 receptor partial agonist, Capeserod, which First Wave will repurpose and develop for gastroin...
2023-09-14 09:07:26 ET (24/7 MARKET NEWS) – First Wave BioPharma, Inc. (NASDAQ:FWBI) stated, this morning, that it signed an agreement to license Sanofi’s (NASDAQ:SNY) selective 5-HT4 receptor partial agonist, Capeserod, which First Wave will repurpose and develop for gastroin...
2023-09-13 10:18:38 ET DENVER, Colo., Sept 13, 2023 ( www.247marketnews.com)- News Rocket Pharmaceuticals Reaches FDA Alignment on Pivotal Phase 2 Trial Design for RP-A501 in Danon Disease AND Rocket Pharmaceuticals Announces Pricing of Public Offering of Common Stock ...
2023-09-13 10:18:38 ET DENVER, Colo., Sept 13, 2023 ( www.247marketnews.com)- News Rocket Pharmaceuticals Reaches FDA Alignment on Pivotal Phase 2 Trial Design for RP-A501 in Danon Disease AND Rocket Pharmaceuticals Announces Pricing of Public Offering of Common Stock ...
2023-09-13 10:18:38 ET DENVER, Colo., Sept 13, 2023 ( www.247marketnews.com)- News Rocket Pharmaceuticals Reaches FDA Alignment on Pivotal Phase 2 Trial Design for RP-A501 in Danon Disease AND Rocket Pharmaceuticals Announces Pricing of Public Offering of Common Stock ...
2023-09-13 09:14:10 ET (24/7 MARKET NEWS) – Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) stated, after yesterday’s market close, that it reached alignment with the Food and Drug Administration (FDA) on the global Phase 2 pivotal trial of RP-A501 for Danon Disease, a uniformly fa...
2023-09-13 07:57:58 ET (24/7 MARKET NEWS) – Mainz Biomed N.V. (NASDAQ:MYNZ) reported, this morning, positive topline results from its ColoFuture study, a multi-center international clinical trial assessing the potential to integrate a portfolio of novel gene expression (mRNA) biomark...
2023-09-11 07:58:47 ET DENVER, Colo., September 11, 2023 ( www.247marketnews.com )- One of the biggest lessons learned from the tragic events of 9/11 is the critical importance of seamless communication among first responders. Two decades later, Siyata Mobile, Inc. (NASDAQ: SYTA), a Can...
DENVER, Colo., July 27, 2020- Moderna (NASDAQ:MRNA) was the weekend’s big Corona winner, as the U.S. government adjusted its existing contract, by increasing funding, by up to $472 million, for a "significantly" larger Phase 3 study of the company's COVID-19 mRNA vaccine candidate (mRNA-1...
DENVER, Colo., July 27, 2020- Moderna (NASDAQ:MRNA) was the weekend’s big Corona winner, as the U.S. government adjusted its existing contract, by increasing funding, by up to $472 million, for a "significantly" larger Phase 3 study of the company's COVID-19 mRNA vaccine candidate (mRNA-1...
News, Short Squeeze, Breakout and More Instantly...
Trending Stock
100.0%Change Percent:
International Petroleum Company Name:
IPCFF Stock Symbol:
OTCMKTS Market:
international-petroleum.com Website: